Neuraxis, INC (NRXS)

↓ Download CSV

CIK 0001933567 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Neuraxis, INC reported revenue of $3.57M, up 32.9% from the prior year. The company ran a net loss, with a net margin of -218.5% and a gross margin of 84.2%. It held $6.40M in total assets against $3.00M in total liabilities.

Key ratios (FY2025)

84.2%
Gross margin
-219.4%
Operating margin
-218.5%
Net margin
-229.5%
Return on equity
+32.9%
Revenue growth (YoY)
Metric (FY)20252024202320222021
Revenue$3.57M$2.69M$2.46M$2.68M
Cost of Revenue$562.9K$362.0K$303.3K$297.1K
Gross Profit$3.01M$2.32M$2.16M$2.39M
Operating Income-$7.83M-$7.16M-$6.66M-$3.37M
Net Income-$7.80M-$8.24M-$14.63M-$4.78M
EPS (Diluted)$-0.95$-1.22$-4.50$-2.77
Total Assets$6.40M$4.76M$509.5K$1.48M
Total Liabilities$3.00M$2.69M$1.91M$7.05M
Shareholders' Equity$3.40M$2.07M-$1.40M-$5.57M-$825.7K
Cash & Equivalents$4.97M$3.70M$78.6K$253.7K
Operating Cash Flow-$6.43M-$6.10M-$6.69M-$2.30M
Capital Expenditures$31.1K$27.8K$30.8K$1.4K
Shares Outstanding10.65M6.99M6.51M1.96M